Ensysce Biosciences, Inc. (ENSC) AI Dilution Summary

Estimated cash was $30,279,695 as of 2026-08-07, rolled forward from $676,704 at 2026-06-30 against estimated monthly burn of $910,564. The most recent capital raised was an unregistered private placement of preferred stock that closed 2026-08-07 with $21,500,000 in gross proceeds. Dilution here is driven primarily by the August 2024 Investor Warrants – 5-year half: 957,233 shares at a fixed $7.05 exercise price, expiring 2029-11-21.